IDEXX Laboratories Stock - Thursday chart check after recent volatility
Published on 06/18/2026 at 17:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:24 CET. Details in the imprint.
IDEXX Laboratories (US45168D1046) develops veterinary diagnostics and software and is part of the Nasdaq-100 index. With no fresh corporate headlines today from major wires or the company itself, the spotlight turns to the current chart setup and valuation levels.
All news and data on IDEXX Laboratories stock
Historical reports, price data and earlier earnings coverage on IDEXX Laboratories can be found in the dedicated topic area on ad-hoc-news.de.
How IDEXX trades this week
After strong Q4 2025 results and 2026 guidance in February, IDEXX Laboratories shares saw a pronounced pullback, including a drop of around 4% on the first trading day after the figures, according to a Seeking Alpha-based summary cited by Intellectia AI.
Bank of America subsequently cut its price target on IDEXX from $790 to $660 while maintaining a Neutral rating, which has contributed to more cautious sentiment around the shares.
Thursday focus on technicals
On European trading platforms such as finanzen100, IDEXX Laboratories recently showed a price around EUR 472.90, equivalent to a mid-$500 range in the U.S. listing when adjusted for exchange rates and ADR-equivalent structure.
That level represents a clear discount to the early-2024 highs, but still prices in solid growth expectations for diagnostics and practice-management software in companion-animal health.
What the company sells
IDEXX Laboratories generates most of its revenue from companion-animal diagnostics, particularly in-clinic analyzers and consumables such as the Catalyst One chemistry analyzer and the ProCyte One hematology system, complemented by reference lab services and VetConnect PLUS software.
Where the stock trades today
The shares of IDEXX Laboratories (US45168D1046) trade on Nasdaq at about $505.00 as of 06/18/2026, 17:24 CET.
IDEXX Laboratories at a glance
- Company: IDEXX Laboratories, Inc.
- ISIN: US45168D1046
- WKN: 888210
- Ticker: IDXX
- Venue: Nasdaq
- Price (as of 06/18/2026, 17:24 CET): 505.00 USD
- Market cap: 42,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: Nasdaq-100, S&P 500
- Next earnings date: 08/01/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
